2015-2025 Global Recombinant Protein Drugs Market Research by Type, End-Use and Region (COVID-19)

July 2020 | 105 pages | ID: 28DEE823C054EN
99Strategy

Abstracts

SUMMARY


The global Recombinant Protein Drugs market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:

• Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
• Chapter 2: Global Production & Consumption Market by Type and End-Use
• Chapter 3: Europe Production & Consumption Market by Type and End-Use
• Chapter 4: America Production & Consumption Market by Type and End-Use
• Chapter 5: Asia Production & Consumption Market by Type and End-Use
• Chapter 6: Oceania Production & Consumption Market by Type and End-Use
• Chapter 7: Africa Production & Consumption Market by Type and End-Use
• Chapter 8: Global Market Forecast by Type, End-Use and Region
• Chapter 9: Company information, Sales, Cost, Margin, news etc.
• Chapter 10: Market Competition by Companies and Market Concentration Ratio
• Chapter 11: Market Impact by Coronavirus.
• Chapter 12: Industry Summary

Market Segment as follows:

Key Companies

• Novo Nordisk
• Amgen
• Sanofi
• Eli Lilly
• Merck Serono
• Ortho Biotech
• Roche
• Kyowa Hakko Kirin
• Pharmingen
• Abcam
• GenSci
• SL PHARM
• Dongbao Pharm
• Ankebio
• NCPC
• Heng Rui

Key Types

• Recombinant DNA
• Recombinant RNA

Key End-Use

• Pharmaceutical Industry
• Others

This report can be dispatched within 24-48 Hours.

Contents

CHAPTER 1 MARKET OVERVIEW

1.1 Market Definition and Segment
  1.1.1 Product Definition
  1.1.2 Product Type
  1.1.3 End-Use
  1.1.4 Marketing Channel
1.2 Major Regions
  1.2.1 Europe Market Size and Growth
Figure Europe Recombinant Protein Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Recombinant Protein Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.2 America Market Size and Growth
Figure America Recombinant Protein Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Recombinant Protein Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.3 Asia Market Size and Growth
Figure Asia Recombinant Protein Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaRecombinant Protein Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.4 Oceania Market Size and Growth
Figure Oceania Recombinant Protein Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Recombinant Protein Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.5 Africa Market Size and Growth
Figure Africa Recombinant Protein Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Recombinant Protein Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

2.1 Global Production Overview
Table Global Recombinant Protein Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Recombinant Protein Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Recombinant Protein Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Global Recombinant Protein Drugs Revenue Share by Type in 2020 (Million USD)
Table Global Recombinant Protein Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Global Recombinant Protein Drugs Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Recombinant Protein Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Recombinant Protein Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Recombinant Protein Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Recombinant Protein Drugs Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Recombinant Protein Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Recombinant Protein Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 EUROPE MARKET SEGMENTATION

3.1 Europe Production Overview
Table Europe Recombinant Protein Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Recombinant Protein Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Recombinant Protein Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Europe Recombinant Protein Drugs Revenue Share by Type in 2020 (Million USD)
Table Europe Recombinant Protein Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Europe Recombinant Protein Drugs Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Recombinant Protein Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Recombinant Protein Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Recombinant Protein Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Recombinant Protein Drugs Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Recombinant Protein Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Recombinant Protein Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

4.1 America Production Overview
Table America Recombinant Protein Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Recombinant Protein Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Recombinant Protein Drugs Revenue by Type, 2015-2020 (Million USD)
Figure America Recombinant Protein Drugs Revenue Share by Type in 2020 (Million USD)
Table America Recombinant Protein Drugs Production Volume by Type, 2015-2020 (Volume)
Figure America Recombinant Protein Drugs Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Recombinant Protein Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Recombinant Protein Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table America Recombinant Protein Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Recombinant Protein Drugs Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Recombinant Protein Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Recombinant Protein Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

5.1 Asia Production Overview
Table Asia Recombinant Protein Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Recombinant Protein Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Recombinant Protein Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Asia Recombinant Protein Drugs Revenue Share by Type in 2020 (Million USD)
Table Asia Recombinant Protein Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Asia Recombinant Protein Drugs Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Recombinant Protein Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Recombinant Protein Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Recombinant Protein Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Recombinant Protein Drugs Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Recombinant Protein Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Recombinant Protein Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

6.1 Oceania Production Overview
Table Oceania Recombinant Protein Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Recombinant Protein Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Recombinant Protein Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Recombinant Protein Drugs Revenue Share by Type in 2020 (Million USD)
Table Oceania Recombinant Protein Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Recombinant Protein Drugs Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Recombinant Protein Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Recombinant Protein Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Recombinant Protein Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Recombinant Protein Drugs Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Recombinant Protein Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Recombinant Protein Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

7.1 Africa Production Overview
Table Africa Recombinant Protein Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Recombinant Protein Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Recombinant Protein Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Africa Recombinant Protein Drugs Revenue Share by Type in 2020 (Million USD)
Table Africa Recombinant Protein Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Africa Recombinant Protein Drugs Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Recombinant Protein Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Recombinant Protein Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Recombinant Protein Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Recombinant Protein Drugs Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Recombinant Protein Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Recombinant Protein Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

8.1 Global Recombinant Protein Drugs Production Forecast
Figure Global Recombinant Protein Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Recombinant Protein Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Recombinant Protein Drugs Forecast by Type
Table Global Recombinant Protein Drugs Revenue by Type, 2020E-2025F (Million USD)
Figure Global Recombinant Protein Drugs Revenue Share by Type in 2025 (Million USD)
Table Global Recombinant Protein Drugs Production Volume by Type, 2020E-2025F (Volume)
Figure Global Recombinant Protein Drugs Production Volume Share by Type in 2025 (Volume)
8.3 Global Recombinant Protein Drugs Forecast by End-Use (2020E-2025F)
Table Global Recombinant Protein Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Recombinant Protein Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Recombinant Protein Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Recombinant Protein Drugs Forecast by Region (2020E-2025F)
Table Global Recombinant Protein Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Recombinant Protein Drugs Consumption Value Share by Region in 2025 (Million USD)
Table Global Recombinant Protein Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Recombinant Protein Drugs Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

9.1 Novo Nordisk
  9.1.1 Novo Nordisk Profile
Table Novo Nordisk Overview List
  9.1.2 Novo Nordisk Products & Services
  9.1.3 Novo Nordisk Company Dynamics & News
  9.1.4 Novo Nordisk Business Operation Conditions
Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Amgen
  9.2.1 Amgen Profile
Table Amgen Overview List
  9.2.2 Amgen Products & Services
  9.2.3 Amgen Company Dynamics & News
  9.2.4 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Sanofi
  9.3.1 Sanofi Profile
Table Sanofi Overview List
  9.3.2 Sanofi Products & Services
  9.3.3 Sanofi Company Dynamics & News
  9.3.4 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Eli Lilly
  9.4.1 Eli Lilly Profile
Table Eli Lilly Overview List
  9.4.2 Eli Lilly Products & Services
  9.4.3 Eli Lilly Company Dynamics & News
  9.4.4 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Merck Serono
  9.5.1 Merck Serono Profile
Table Merck Serono Overview List
  9.5.2 Merck Serono Products & Services
  9.5.3 Merck Serono Company Dynamics & News
  9.5.4 Merck Serono Business Operation Conditions
Table Business Operation of Merck Serono (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Ortho Biotech
  9.6.1 Ortho Biotech Profile
Table Ortho Biotech Overview List
  9.6.2 Ortho Biotech Products & Services
  9.6.3 Ortho Biotech Company Dynamics & News
  9.6.4 Ortho Biotech Business Operation Conditions
Table Business Operation of Ortho Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Roche
  9.7.1 Roche Profile
Table Roche Overview List
  9.7.2 Roche Products & Services
  9.7.3 Roche Company Dynamics & News
  9.7.4 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Kyowa Hakko Kirin
  9.8.1 Kyowa Hakko Kirin Profile
Table Kyowa Hakko Kirin Overview List
  9.8.2 Kyowa Hakko Kirin Products & Services
  9.8.3 Kyowa Hakko Kirin Company Dynamics & News
  9.8.4 Kyowa Hakko Kirin Business Operation Conditions
Table Business Operation of Kyowa Hakko Kirin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Pharmingen
  9.9.1 Pharmingen Profile
Table Pharmingen Overview List
  9.9.2 Pharmingen Products & Services
  9.9.3 Pharmingen Company Dynamics & News
  9.9.4 Pharmingen Business Operation Conditions
Table Business Operation of Pharmingen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Abcam
  9.10.1 Abcam Profile
Table Abcam Overview List
  9.10.2 Abcam Products & Services
  9.10.3 Abcam Company Dynamics & News
  9.10.4 Abcam Business Operation Conditions
Table Business Operation of Abcam (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 GenSci
  9.11.1 GenSci Profile
Table GenSci Overview List
  9.11.2 GenSci Products & Services
  9.11.3 GenSci Company Dynamics & News
  9.11.4 GenSci Business Operation Conditions
Table Business Operation of GenSci (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 SL PHARM
  9.12.1 SL PHARM Profile
Table SL PHARM Overview List
  9.12.2 SL PHARM Products & Services
  9.12.3 SL PHARM Company Dynamics & News
  9.12.4 SL PHARM Business Operation Conditions
Table Business Operation of SL PHARM (Sales Revenue, Cost, Gross Margin)
9.13 Dongbao Pharm
  9.13.1 Dongbao Pharm Profile
Table Dongbao Pharm Overview List
  9.13.2 Dongbao Pharm Products & Services
  9.13.3 Dongbao Pharm Company Dynamics & News
  9.13.4 Dongbao Pharm Business Operation Conditions
Table Business Operation of Dongbao Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Ankebio
  9.14.1 Ankebio Profile
Table Ankebio Overview List
  9.14.2 Ankebio Products & Services
  9.14.3 Ankebio Company Dynamics & News
  9.14.4 Ankebio Business Operation Conditions
Table Business Operation of Ankebio (Sales Revenue, Cost, Gross Margin)
9.15 NCPC
  9.15.1 NCPC Profile
Table NCPC Overview List
  9.15.2 NCPC Products & Services
  9.15.3 NCPC Company Dynamics & News
  9.15.4 NCPC Business Operation Conditions
Table Business Operation of NCPC (Sales Revenue, Cost, Gross Margin)
9.16 Heng Rui
  9.16.1 Heng Rui Profile
Table Heng Rui Overview List
  9.16.2 Heng Rui Products & Services
  9.16.3 Heng Rui Company Dynamics & News
  9.16.4 Heng Rui Business Operation Conditions
Table Business Operation of Heng Rui (Sales Revenue, Cost, Gross Margin)

PART 10 MARKET COMPETITION

10.1 Key Company Market Share
Table Global Recombinant Protein Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Recombinant Protein Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Recombinant Protein Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Recombinant Protein Drugs Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Recombinant Protein Drugs Market Concentration Ratio in 2020E
Figure America Recombinant Protein Drugs Market Concentration Ratio in 2020E
Figure Asia Recombinant Protein Drugs Market Concentration Ratio in 2020E
Figure Oceania Recombinant Protein Drugs Market Concentration Ratio in 2020E
Figure Africa Recombinant Protein Drugs Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON RECOMBINANT PROTEIN DRUGS INDUSTRY

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 RECOMBINANT PROTEIN DRUGS INDUSTRY SUMMARY & CONCLUSION

List Of Tables

LIST OF TABLES
Table Global Recombinant Protein Drugs Revenue by Type, 2015-2020 (Million USD)
Table Global Recombinant Protein Drugs Production Volume by Type, 2015-2020 (Volume)
Table Global Recombinant Protein Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Recombinant Protein Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Recombinant Protein Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Recombinant Protein Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Recombinant Protein Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Recombinant Protein Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Recombinant Protein Drugs Revenue by Type, 2015-2020 (Million USD)
Table Europe Recombinant Protein Drugs Production Volume by Type, 2015-2020 (Volume)
Table Europe Recombinant Protein Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Recombinant Protein Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Recombinant Protein Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Recombinant Protein Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table America Recombinant Protein Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Recombinant Protein Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Recombinant Protein Drugs Revenue by Type, 2015-2020 (Million USD)
Table America Recombinant Protein Drugs Production Volume by Type, 2015-2020 (Volume)
Table America Recombinant Protein Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Recombinant Protein Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Recombinant Protein Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Recombinant Protein Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Recombinant Protein Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Recombinant Protein Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Recombinant Protein Drugs Revenue by Type, 2015-2020 (Million USD)
Table Asia Recombinant Protein Drugs Production Volume by Type, 2015-2020 (Volume)
Table Asia Recombinant Protein Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Recombinant Protein Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Recombinant Protein Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Recombinant Protein Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Recombinant Protein Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Recombinant Protein Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Recombinant Protein Drugs Revenue by Type, 2015-2020 (Million USD)
Table Oceania Recombinant Protein Drugs Production Volume by Type, 2015-2020 (Volume)
Table Oceania Recombinant Protein Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Recombinant Protein Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Recombinant Protein Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Recombinant Protein Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Recombinant Protein Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Recombinant Protein Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Recombinant Protein Drugs Revenue by Type, 2015-2020 (Million USD)
Table Africa Recombinant Protein Drugs Production Volume by Type, 2015-2020 (Volume)
Table Africa Recombinant Protein Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Recombinant Protein Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Recombinant Protein Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Recombinant Protein Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Global Recombinant Protein Drugs Revenue by Type, 2020E-2025F (Million USD)
Table Global Recombinant Protein Drugs Production Volume by Type, 2020E-2025F (Volume)
Table Global Recombinant Protein Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Recombinant Protein Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Recombinant Protein Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Recombinant Protein Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Table Novo Nordisk Overview List
Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Serono Overview List
Table Business Operation of Merck Serono (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ortho Biotech Overview List
Table Business Operation of Ortho Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kyowa Hakko Kirin Overview List
Table Business Operation of Kyowa Hakko Kirin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharmingen Overview List
Table Business Operation of Pharmingen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abcam Overview List
Table Business Operation of Abcam (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GenSci Overview List
Table Business Operation of GenSci (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table SL PHARM Overview List
Table Business Operation of SL PHARM (Sales Revenue, Cost, Gross Margin)
Table Dongbao Pharm Overview List
Table Business Operation of Dongbao Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ankebio Overview List
Table Business Operation of Ankebio (Sales Revenue, Cost, Gross Margin)
Table NCPC Overview List
Table Business Operation of NCPC (Sales Revenue, Cost, Gross Margin)
Table Heng Rui Overview List
Table Business Operation of Heng Rui (Sales Revenue, Cost, Gross Margin)
Table Global Recombinant Protein Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Recombinant Protein Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Recombinant Protein Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Recombinant Protein Drugs Sales Volume Share by Companies, 2015-2020E (Volume)

List Of Figures

LIST OF FIGURES
Figure Europe Recombinant Protein Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Recombinant Protein Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Recombinant Protein Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Recombinant Protein Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Recombinant Protein Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaRecombinant Protein Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Recombinant Protein Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Recombinant Protein Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Recombinant Protein Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Recombinant Protein Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Recombinant Protein Drugs Revenue Share by Type in 2020 (Million USD)
Figure Global Recombinant Protein Drugs Production Volume Share by Type in 2020 (Volume)
Figure Global Recombinant Protein Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Recombinant Protein Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Recombinant Protein Drugs Revenue Share by Type in 2020 (Million USD)
Figure Europe Recombinant Protein Drugs Production Volume Share by Type in 2020 (Volume)
Figure Europe Recombinant Protein Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Recombinant Protein Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Recombinant Protein Drugs Revenue Share by Type in 2020 (Million USD)
Figure America Recombinant Protein Drugs Production Volume Share by Type in 2020 (Volume)
Figure America Recombinant Protein Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Recombinant Protein Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Recombinant Protein Drugs Revenue Share by Type in 2020 (Million USD)
Figure Asia Recombinant Protein Drugs Production Volume Share by Type in 2020 (Volume)
Figure Asia Recombinant Protein Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Recombinant Protein Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Recombinant Protein Drugs Revenue Share by Type in 2020 (Million USD)
Figure Oceania Recombinant Protein Drugs Production Volume Share by Type in 2020 (Volume)
Figure Oceania Recombinant Protein Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Recombinant Protein Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Recombinant Protein Drugs Revenue Share by Type in 2020 (Million USD)
Figure Africa Recombinant Protein Drugs Production Volume Share by Type in 2020 (Volume)
Figure Africa Recombinant Protein Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Recombinant Protein Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Recombinant Protein Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Recombinant Protein Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Recombinant Protein Drugs Revenue Share by Type in 2025 (Million USD)
Figure Global Recombinant Protein Drugs Production Volume Share by Type in 2025 (Volume)
Figure Global Recombinant Protein Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Recombinant Protein Drugs Consumption Value Share by Region in 2025 (Million USD)
Figure Global Recombinant Protein Drugs Consumption Volume Share by Region in 2025 (Volume)